Provider
Interleukin-31 (IL-31) Inhibitor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
2026 Small Group Vision Benefit Summaries
Program effective Date: Oct 09, 2024
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025